Home/Pheno Therapeutics/Fraser Murray, PhD
FM

Fraser Murray, PhD

CEO

Pheno Therapeutics

Pheno Therapeutics Pipeline

DrugIndicationPhase
PTD802Multiple SclerosisPhase 1